Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/stat6 pathway

Dirk Homann, Andreas Holz, Adrian Bot, Bryan Coon, Tom Wolfe, Jacob Petersen, Thomas P. Dyrberg, Michael J. Grusby, Matthias G. Von Herrath

Research output: Contribution to journalArticlepeer-review

172 Scopus citations

Abstract

Targeted immune regulation can be achieved by use of tissue-specific T cells and offers the potential for organ-specific suppression of destructive autoimmune processes. Here, we report the generation and characterization of insulin B chain-specific 'autoreactive' CD4+ regulatory T cells that locally suppress diabetogenic T cell responses against an unrelated self-antigen (viral transgene) in a virus-induced model for type I diabetes. Interleukin 4 (IL-4) is essential for prevention of diabetes since regulatory T cells cannot be induced in the absence of IL-4 or stat6 (IL-4 signaling pathway). Our observations demonstrate that autoreactive regulatory T cells can suppress autoreactive destructive T cell activity of differential antigenic specificity locally in the pancreatic draining lymph node, probably via cytokine-mediated modulation of antigen-presenting cells.

Original languageEnglish
Pages (from-to)463-472
Number of pages10
JournalImmunity
Volume11
Issue number4
DOIs
StatePublished - Oct 1999
Externally publishedYes

Fingerprint

Dive into the research topics of 'Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/stat6 pathway'. Together they form a unique fingerprint.

Cite this